日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Biopsychosocial Overview of Speech Disorders: Neuroanatomical, Genetic, and Environmental Insights

言语障碍的生物心理社会学概述:神经解剖学、遗传学和环境因素的见解

Jaishankar, Diya; Raghuram, Tanvi; Raju, Bhuvanesh Kumar; Swarna, Divyanka; Parekh, Shriya; Chirmule, Narendra; Gujar, Vikramsingh

Understanding preclinical and clinical immunogenicity risks in novel biotherapeutics development

了解新型生物疗法研发中的临床前和临床免疫原性风险

Sauna, Zuben E; Jawa, Vibha; Balu-Iyer, Sathy; Chirmule, Narendra

A four-part guide to lung immunology: Invasion, inflammation, immunity, and intervention

肺部免疫学四部分指南:侵袭、炎症、免疫和干预

Gopallawa, Indiwari; Dehinwal, Ruchika; Bhatia, Vaibhav; Gujar, Vikramsingh; Chirmule, Narendra

An Overview of Current Accomplishments and Gaps of COVID-19 Vaccine Platforms and Considerations for Next Generation Vaccines

新冠肺炎疫苗平台现状及不足概述及下一代疫苗的考量

Kale, Akanksha; Gaur, Amitabh; Menon, Ipshita; Chirmule, Narendra; Bagwe, Priyal; Jawa, Rayan; Vijayanand, Sharon; Patil, Smital; Suresh, Surekha; Jawa, Vibha

Digital health initiatives can take better cognizance of marginalized communities in India

数字健康计划可以更好地关注印度的边缘化群体。

Khaimani, Jatin; Singh Bhatia, Angad P; Jeurkar, Arnav; Rao, Dipti; Chirmule, Narendra; Misra, Pallavi; Kadam, Rajashree; Karuppieh, Santhiya; Seshadrinathan, Shruthy; Sheth, Smritie

Biopharmaceutical Industry Capability Building in India: Report from a Symposium

印度生物制药产业能力建设:研讨会报告

Uppal, Annu; Chakrabarti, Ranjan; Chirmule, Narendra; Rathore, Anurag; Atouf, Fouad

Understanding Quality Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP Quality Advisory Group

理解不断变化的制药格局中的质量范式转变:来自美国药典质量咨询小组的视角

Weitzel, Jane; Pappa, Horacio; Banik, Gregory M; Barker, Amy R; Bladen, Elizabeth; Chirmule, Narendra; DeFeo, Joseph; Devine, Jennifer; Emrick, Steven; Hout, Taha Kass; Levy, Michael S; Mahlangu, Gugu N; Rellahan, Barbara; Venema, Jaap; Workman, Wesley

Utility of a Bayesian Mathematical Model to Predict the Impact of Immunogenicity on Pharmacokinetics of Therapeutic Proteins

贝叶斯数学模型在预测免疫原性对治疗性蛋白质药代动力学影响方面的应用

Kathman, Steven Jr; Thway, Theingi M; Zhou, Lei; Lee, Stephanie; Yu, Steven; Ma, Mark; Chirmule, Naren; Jawa, Vibha

Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications

生物治疗药物的免疫原性:原因及与翻译后修饰的关系

Kuriakose, Anshu; Chirmule, Narendra; Nair, Pradip

Blockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus

阻断干扰素-γ可使系统性红斑狼疮患者的干扰素调节基因表达和血清CXCL10水平恢复正常

Andrew A Welcher ,Michael Boedigheimer ,Alan J Kivitz ,Zahir Amoura ,Jill Buyon ,Alla Rudinskaya ,Kevin Latinis ,Kit Chiu ,Kelly S Oliner ,Michael A Damore ,Gregory E Arnold ,Winnie Sohn ,Narendra Chirmule ,Lovely Goyal ,Christopher Banfield ,James B Chung